Kurz gefasst
Editorial in der Zeitschrift Science, 2023. Verfasst von Ann Linder und 1 weiteren Autor:innen. Beteiligte Einrichtung: Ann Linder is at the Brooks McCormick Jr. Animal Law and Policy Program, Harvard Law School, Cambridge, MA, USA. Hauptthemen laut MEDLINE: Bioterrorism, Zoonoses, Biosecurity, Biohazard Release. Die Arbeit wurde bisher 8-mal zitiert (Crossref).
Abstract (Originalsprache)
In October, the Biden administration released its National Biodefense Strategy (NBS-22), the first update since the COVID-19 pandemic began. Although the document notes that one of the lessons of the pandemic is that threats originating anywhere are threats everywhere, it frames threats as largely external to the United States. NBS-22 focuses primarily on bioterrorism and laboratory accidents, neglecting threats posed by routine practices of animal use and production inside the United States. NBS-22 references zoonotic disease but assures readers that no new legal authorities or institutional innovations are needed. Although the US is not alone in failing to confront these risks, its failure to comprehensively address them echoes across the globe.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Ann Linder is at the Brooks McCormick Jr. Animal Law and Policy Program, Harvard Law School, Cambridge, MA, USA.
- Dale Jamieson is at the Center for Environmental and Animal Protection, Department of Environmental Studies, New York University, New York, NY, USA.
Zitieren
APA
Linder, A., & Jamieson, D. (2023). Blind spots in biodefense. Science. https://doi.org/10.1126/science.adg9237
Vancouver
Linder A, Jamieson D. Blind spots in biodefense. Science. 2023. doi:10.1126/science.adg9237
BibTeX
@article{Linder2023,
author = {Linder, Ann and Jamieson, Dale},
title = {Blind spots in biodefense},
journal = {Science},
year = {2023},
doi = {10.1126/science.adg9237}
}
EUVIMED